Key result
CANNeCTIN initiative trains 11 biostatistics trainees to boost Canadian cardiovascular and diabetes trial capacity.
Why the study?
The CANNeCTIN Biostatistics and Methodological Innovation Working Group was established to enhance infrastructure, advance biostatistical and methodological research, and build capacity for large Canadian-led clinical trials in cardiovascular diseases and diabetes mellitus.
Answers are grounded in this paper and cite their sources.
Describes a Canadian collaborative network model for building biostatistical and methodological capacity to support large-scale cardiovascular and diabetes clinical trials.
The Biostatistics and Methodological Innovation Working (BMIW) Group is one of several working groups within the CANadian Network and Centre for Trials INternationally (CANNeCTIN). This programme received funding from the Canadian Institutes of Health Research and the Canada Foundation for Innovation beginning in 2008, to enhance the infrastructure and build capacity for large Canadian-led clinical trials in cardiovascular diseases (CVD) and diabetes mellitus (DM). The overall aims of the BMIW Group's programme within CANNeCTIN, are to advance biostatistical and methodological research, and to build biostatistical capacity in CVD and DM. Our program of research and training includes: monthly videoconferences on topical biostatistical and methodological issues in CVD/DM clinical studies; providing presentations on methods issues at the annual CANNeCTIN meetings; collaborating with clinician investigators on their studies; training young statisticians in biostatistics and methods in CVD/DM trials and organizing annual symposiums on topical methodological issues. We are focused on the development of new biostatistical methods and the recruitment and training of highly qualified personnel--who will become leaders in the design and analysis of CVD/DM trials. The ultimate goal is to enhance global health by contributing to efforts to reduce the burden of CVD and DM.
No takes yet. Share an insight, caveat, or question.
Thabane et al. (2011) studied Cardiovascular diseases and diabetes mellitus. CANNeCTIN Biostatistics and Methodological Innovation Working Group programme was evaluated. The CANNeCTIN Biostatistics and Methodological Innovation Working Group trained 11 biostatistics trainees across 4 Canadian universities to build capacity in cardiovascular and diabetes trials.
Synapse has enriched 10 related papers. Consider them for comparative context: